SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-02-041199
Filing Date
2002-11-06
Accepted
2002-11-06 17:27:42
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II LPBVF INCBVF PARTNERS LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a2092648zsc13da.htm SC 13D/A 69732
3 EXHIBIT A a2092648zex-99_1.htm EX-99.1 8961
  Complete submission text file 0000912057-02-041199.txt   80997
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

IRS No.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78237 | Film No.: 02811645
SIC: 2834 Pharmaceutical Preparations